Yuvaraj Singh
Worcester, MANPI 1992359517
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $504 and has fallen 82.9% since, to $86 in 2025.
Across 83 payments — averaging $26.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$491
- AbbVie$385
- E.r. Squibb & Sons, L.L.C.$240
- Gilead$221
- Takeda Pharmaceuticals U.S.A., Inc.$179
- Pfizer$143
- plus $546 from 13 others
What the payments were for
- Food & beverage$2,19199%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 19 | $491 |
| AbbVie | 8 | $385 |
| E.r. Squibb & Sons, L.L.C. | 14 | $240 |
| Gilead | 10 | $221 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $179 |
| Pfizer | 10 | $143 |
| Alcresta Therapeutics, Inc. | 2 | $116 |
| Sanofi | 1 | $86 |
| Novo Nordisk | 2 | $84 |
| Bayer | 2 | $48 |
| Boehringer Ingelheim | 3 | $48 |
| Karyopharm Therapeutics Inc. | 2 | $32 |
| Boston Scientific | 1 | $27 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Viiv Healthcare Company | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Fresenius Kabi USA, LLC | 1 | $16 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $15 |
| GSK | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Entyvio$122
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.